Kintara Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.977; its P/E ratio is -0.02; Kintara Therapeutics is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -1.02M	$ -2.96M	$ -3.26M	$ -3.45M	-
EBITDA	$ -1.01M	$ -2.95M	$ -2.17M	$ -2.36M	-
Net Income Common Stockholders	$ -1.02M	$ -3.14M	$ -3.27M	$ 3.54M	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 658.00K	$ 216.00K	$ 3.04M	$ 4.87M	-
Total Assets	$ 1.89M	$ 1.48M	$ 6.74M	$ 9.92M	-
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -658.00K	$ -216.00K	$ -3.04M	$ -4.87M	$ 0.00
Total Liabilities	$ 2.05M	$ 3.50M	$ 2.95M	$ 3.32M	-
Stockholders Equity	$ -164.00K	$ -2.03M	$ 3.79M	$ 6.60M	-
Cash Flow	-
Free Cash Flow	$ -2.14M	$ -1.32M	$ -1.83M	$ -2.16M	-
Operating Cash Flow	$ -2.12M	$ -1.32M	$ -1.83M	$ -2.16M	-
Investing Cash Flow	$ -20.00K	-	-	-	-
Financing Cash Flow	$ 2.58M	$ -2.00K	$ -2.00K	$ -50.00K	-

Currency in USD

Kintara Therapeutics Earnings and Revenue History

Income Statement >

Kintara Therapeutics Debt to Assets

Balance Sheet >

Kintara Therapeutics Cash Flow

Cash Flow >

Kintara Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing